相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autoimmune Thyroid Disease Elicited by NY-ESO-1 Vaccination
Roberto Vita et al.
THYROID (2014)
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
S. F. Slovin et al.
ANNALS OF ONCOLOGY (2013)
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
Saskia J. A. M. Santegoets et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The EFIS-EJI Ruggero Ceppellini Advanced School of Immunology Innate Immunity 2012: From Evolution to Revolution
Antonio Di Giacomo
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
Dung T. Le et al.
JOURNAL OF IMMUNOTHERAPY (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
Francesco Torino et al.
THYROID (2013)
Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Comparison of Different Assays and Evaluation of Causes of Discrepancies
Francesco Latrofa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
Alfons J. M. van den Eertwegh et al.
LANCET ONCOLOGY (2012)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
Jianda Yuan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches
Edward Cha et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Concordance between thyroglobulin antibody assays
Kevin P. Taylor et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
Autoimmune hypothyroidism and granulocyte-macrophage colony-stimulating factor
Per Boye Hansen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription Factor
Rehan Ahmad et al.
CANCER RESEARCH (2009)
Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring
John Krahn et al.
CLINICAL BIOCHEMISTRY (2009)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Jeffrey Weber et al.
CLINICAL CANCER RESEARCH (2009)
The incidence of autoimmune thyroid disease: a systematic review of the literature
Anita McGrogan et al.
CLINICAL ENDOCRINOLOGY (2008)
Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies
Francesco Latrofa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G. Downey et al.
CLINICAL CANCER RESEARCH (2007)
GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action
Andrew D. Simmons et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients
RM Luiten et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization
H Kimura et al.
ENDOCRINOLOGY (2005)
Immunoassay of anti-thyroid autoantibodies: High analytical variability in second generation methods
R Tozzoli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
分享论文
